Report Detail

Request for Sample of this report

Pharma & Healthcare Global Nausea And Vomiting Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4713243
    • |
  • 29 June, 2026
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Nausea And Vomiting Treatment market size was valued at US$ 6412 million in 2025 and is forecast to a readjusted size of US$ 9819 million by 2032 with a CAGR of 6.3% during review period.
Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
This report is a detailed and comprehensive analysis for global Nausea And Vomiting Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nausea And Vomiting Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Nausea And Vomiting Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Nausea And Vomiting Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Nausea And Vomiting Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nausea And Vomiting Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nausea And Vomiting Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Nausea And Vomiting Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
Market segment by Application
CINV
PONV
Motion Sickness
Pregnancy
Others
Market segment by players, this report covers
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Pharmanovia
Mylan
Duchesnay
GSK
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nausea And Vomiting Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nausea And Vomiting Treatment, with revenue, gross margin, and global market share of Nausea And Vomiting Treatment from 2021 to 2026.
Chapter 3, the Nausea And Vomiting Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Nausea And Vomiting Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nausea And Vomiting Treatment.
Chapter 13, to describe Nausea And Vomiting Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nausea And Vomiting Treatment by Type
    • 1.3.1 Overview: Global Nausea And Vomiting Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Nausea And Vomiting Treatment Consumption Value Market Share by Type in 2025
    • 1.3.3 Serotonin Receptor Antagonist
    • 1.3.4 Neurokinin NK1 Receptor Antagonist
    • 1.3.5 Others
  • 1.4 Global Nausea And Vomiting Treatment Market by Application
    • 1.4.1 Overview: Global Nausea And Vomiting Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 CINV
    • 1.4.3 PONV
    • 1.4.4 Motion Sickness
    • 1.4.5 Pregnancy
    • 1.4.6 Others
  • 1.5 Global Nausea And Vomiting Treatment Market Size & Forecast
  • 1.6 Global Nausea And Vomiting Treatment Market Size and Forecast by Region
    • 1.6.1 Global Nausea And Vomiting Treatment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Nausea And Vomiting Treatment Market Size by Region, (2021-2032)
    • 1.6.3 North America Nausea And Vomiting Treatment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Nausea And Vomiting Treatment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Nausea And Vomiting Treatment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Nausea And Vomiting Treatment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Nausea And Vomiting Treatment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Merck & Co. Inc.
    • 2.1.1 Merck & Co. Inc. Details
    • 2.1.2 Merck & Co. Inc. Major Business
    • 2.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Product and Solutions
    • 2.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck & Co. Inc. Recent Developments and Future Plans
  • 2.2 Helsinn Group
    • 2.2.1 Helsinn Group Details
    • 2.2.2 Helsinn Group Major Business
    • 2.2.3 Helsinn Group Nausea And Vomiting Treatment Product and Solutions
    • 2.2.4 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Helsinn Group Recent Developments and Future Plans
  • 2.3 Unimed Pharmaceuticals (AbbVie Inc.)
    • 2.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Details
    • 2.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Major Business
    • 2.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product and Solutions
    • 2.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments and Future Plans
  • 2.4 Kyowa Kirin
    • 2.4.1 Kyowa Kirin Details
    • 2.4.2 Kyowa Kirin Major Business
    • 2.4.3 Kyowa Kirin Nausea And Vomiting Treatment Product and Solutions
    • 2.4.4 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Kyowa Kirin Recent Developments and Future Plans
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Nausea And Vomiting Treatment Product and Solutions
    • 2.5.4 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sanofi Recent Developments and Future Plans
  • 2.6 Qilu Pharma
    • 2.6.1 Qilu Pharma Details
    • 2.6.2 Qilu Pharma Major Business
    • 2.6.3 Qilu Pharma Nausea And Vomiting Treatment Product and Solutions
    • 2.6.4 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Qilu Pharma Recent Developments and Future Plans
  • 2.7 Teva Pharmaceutical Industries Ltd.
    • 2.7.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.7.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product and Solutions
    • 2.7.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
  • 2.8 Taiji group
    • 2.8.1 Taiji group Details
    • 2.8.2 Taiji group Major Business
    • 2.8.3 Taiji group Nausea And Vomiting Treatment Product and Solutions
    • 2.8.4 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Taiji group Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Nausea And Vomiting Treatment Product and Solutions
    • 2.9.4 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Heron Therapeutics
    • 2.10.1 Heron Therapeutics Details
    • 2.10.2 Heron Therapeutics Major Business
    • 2.10.3 Heron Therapeutics Nausea And Vomiting Treatment Product and Solutions
    • 2.10.4 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Heron Therapeutics Recent Developments and Future Plans
  • 2.11 Pharmanovia
    • 2.11.1 Pharmanovia Details
    • 2.11.2 Pharmanovia Major Business
    • 2.11.3 Pharmanovia Nausea And Vomiting Treatment Product and Solutions
    • 2.11.4 Pharmanovia Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Pharmanovia Recent Developments and Future Plans
  • 2.12 Mylan
    • 2.12.1 Mylan Details
    • 2.12.2 Mylan Major Business
    • 2.12.3 Mylan Nausea And Vomiting Treatment Product and Solutions
    • 2.12.4 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Mylan Recent Developments and Future Plans
  • 2.13 Duchesnay
    • 2.13.1 Duchesnay Details
    • 2.13.2 Duchesnay Major Business
    • 2.13.3 Duchesnay Nausea And Vomiting Treatment Product and Solutions
    • 2.13.4 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Duchesnay Recent Developments and Future Plans
  • 2.14 GSK
    • 2.14.1 GSK Details
    • 2.14.2 GSK Major Business
    • 2.14.3 GSK Nausea And Vomiting Treatment Product and Solutions
    • 2.14.4 GSK Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 GSK Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nausea And Vomiting Treatment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Nausea And Vomiting Treatment by Company Revenue
    • 3.2.2 Top 3 Nausea And Vomiting Treatment Players Market Share in 2025
    • 3.2.3 Top 6 Nausea And Vomiting Treatment Players Market Share in 2025
  • 3.3 Nausea And Vomiting Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Nausea And Vomiting Treatment Market: Region Footprint
    • 3.3.2 Nausea And Vomiting Treatment Market: Company Product Type Footprint
    • 3.3.3 Nausea And Vomiting Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nausea And Vomiting Treatment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Nausea And Vomiting Treatment Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Nausea And Vomiting Treatment Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Nausea And Vomiting Treatment Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Nausea And Vomiting Treatment Consumption Value by Type (2021-2032)
  • 6.2 North America Nausea And Vomiting Treatment Market Size by Application (2021-2032)
  • 6.3 North America Nausea And Vomiting Treatment Market Size by Country
    • 6.3.1 North America Nausea And Vomiting Treatment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Nausea And Vomiting Treatment Consumption Value by Type (2021-2032)
  • 7.2 Europe Nausea And Vomiting Treatment Consumption Value by Application (2021-2032)
  • 7.3 Europe Nausea And Vomiting Treatment Market Size by Country
    • 7.3.1 Europe Nausea And Vomiting Treatment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 7.3.3 France Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Nausea And Vomiting Treatment Consumption Value by Region (2021-2032)
    • 8.3.2 China Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 8.3.5 India Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Nausea And Vomiting Treatment Consumption Value by Type (2021-2032)
  • 9.2 South America Nausea And Vomiting Treatment Consumption Value by Application (2021-2032)
  • 9.3 South America Nausea And Vomiting Treatment Market Size by Country
    • 9.3.1 South America Nausea And Vomiting Treatment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Nausea And Vomiting Treatment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Nausea And Vomiting Treatment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Nausea And Vomiting Treatment Market Drivers
  • 11.2 Nausea And Vomiting Treatment Market Restraints
  • 11.3 Nausea And Vomiting Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Nausea And Vomiting Treatment Industry Chain
  • 12.2 Nausea And Vomiting Treatment Upstream Analysis
  • 12.3 Nausea And Vomiting Treatment Midstream Analysis
  • 12.4 Nausea And Vomiting Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Nausea And Vomiting Treatment. Industry analysis & Market Report on Nausea And Vomiting Treatment is a syndicated market report, published as Global Nausea And Vomiting Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Nausea And Vomiting Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo